Daily FNArena News

Forex.com’s Kathleen Brooks reflects on Europe, the Fed and what’s going on in equity markets.

Daily update on share prices and consensus price targets.

Central banks across the globe are looking to to diversify away from the dodgy greenback.

This week’s Tweets by Your Editor on Twitter.

REVA Medical has seen the timeline for starting clinical trials of its bioresorbable stent slip but Bell Potter says any associated share price weakness would be a buying opportunity.

Barclays Capital has analysed seasonal trends for September.

PFP Wealth Management’s Tim Price reviews the book ‘Extreme Money – Masters of the Universe and the Cult of Risk’, which suggests the world needs reduce debt and shrink the financial part of the economy.

A profit result better than guidance and expectations of further growth lead Microequities to retain a Strong Buy rating on IT junior BigAir.

The Chartist suggests a “significant low” has likely been seen for National Australia Bank shares.

ATW’s Jerry Simmons reports the rally in US equities might find the going tougher as strong technical resistance is looming.